120 related articles for article (PubMed ID: 10651131)
21. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
[TBL] [Abstract][Full Text] [Related]
23. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
[TBL] [Abstract][Full Text] [Related]
24. BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo.
Bischoff E; Schramm M; Straub A; Feurer A; Stasch JP
Urology; 2003 Feb; 61(2):464-7. PubMed ID: 12597982
[TBL] [Abstract][Full Text] [Related]
25. Intracavernosal administration of sodium nitrite as an erectile pharmacotherapy.
Lasker GF; Matt CJ; Badejo AM; Casey DB; Dhaliwal JS; Murthy SN; Kadowitz PJ
Can J Physiol Pharmacol; 2010 Jul; 88(7):770-6. PubMed ID: 20651825
[TBL] [Abstract][Full Text] [Related]
26. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Floth A; Schramek P
J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
[TBL] [Abstract][Full Text] [Related]
27. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
28. Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
Martinez-Piñeiro L; Lopez-Tello J; Alonso Dorrego JM; Cisneros J; Cuervo E; Martinez-Piñeiro JA
J Urol; 1995 May; 153(5):1487-90. PubMed ID: 7714974
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM; Stevenson RW; Szasz G
J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
[TBL] [Abstract][Full Text] [Related]
30. A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection.
Bischoff E; Schneider K
Int J Impot Res; 2001 Aug; 13(4):230-5. PubMed ID: 11494080
[TBL] [Abstract][Full Text] [Related]
31. Experience with triple-drug therapy in a pharmacological erection program.
Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
[TBL] [Abstract][Full Text] [Related]
32. Sodium nitroprusside: physiologic effects as a nitric oxide donor in three species.
Trigo-Rocha F; Martinez-Piñeiro L; Donatucci CF; Hsu GL; Lue TF; Tanagho EA
Int J Impot Res; 1995 Mar; 7(1):49-56. PubMed ID: 7670593
[TBL] [Abstract][Full Text] [Related]
33. The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits.
Kang KK; Choi SM; Ahn GJ; Kwon JW; Kim WB
Urol Res; 2004 May; 32(2):107-11. PubMed ID: 15024530
[TBL] [Abstract][Full Text] [Related]
34. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
[TBL] [Abstract][Full Text] [Related]
35. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
36. [Tyr1]-nociceptin and nociceptin have similar naloxone-insensitive erectile activity in the cat.
Champion HC; Bivalacqua TJ; Wang R; Hellstrom WJ; Kadowitz PJ
J Androl; 1998; 19(6):747-53. PubMed ID: 9876026
[TBL] [Abstract][Full Text] [Related]
37. Effect of intraurethral papaverine on penile erection in rats.
Tarhan F; Eryildirim B; Karaalp A; Akbuğa J; Oktay S; Kuyumcuoğlul U
Int Urol Nephrol; 2004; 36(2):219-22. PubMed ID: 15368698
[TBL] [Abstract][Full Text] [Related]
38. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
Sahin M; Başar MM; Bozdoğan O; Atan A
Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamics of penile erection: III. Measurement of deep intracavernosal and subtunical blood flow and oxygen tension.
Azadzoi KM; Vlachiotis J; Pontari M; Siroky MB
J Urol; 1995 Feb; 153(2):521-6. PubMed ID: 7815637
[TBL] [Abstract][Full Text] [Related]
40. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
